BNT211-01: A phase I trial to evaluate safety and efficacy of CLDN6 CAR T cells and CLDN6-encoding mRNA vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumours

Mackensen, A. and Haanen, J. B. A. G. and Koenecke, C. and Alsdorf, W. and Wagner-Drouet, E. and Heudobler, D. and Borchmann, P. and Bokemeyer, C. and Klobuch, S. and Smit, E. and Mueller, F. and Desuki, A. and Lueke, F. and Wiegert, E. and Flemmig, C. and Schulz-Eying, C. and Rengstl, B. and Preussner, L. and Tuereci, O. and Sahin, U. (2022) BNT211-01: A phase I trial to evaluate safety and efficacy of CLDN6 CAR T cells and CLDN6-encoding mRNA vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumours. ANNALS OF ONCOLOGY, 33 (Suppl7). S1404-S1405. ISSN 0923-7534, 1569-8041

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 04 Jul 2024 09:57
Last Modified: 04 Jul 2024 09:57
URI: https://pred.uni-regensburg.de/id/eprint/58386

Actions (login required)

View Item View Item